DIRC2 Polyclonal Antibody

Rabbit Anti-DIRC2 Polyclonal Antibody

Product Specifications

Background

DIRC2 encodes a membrane-bound protein from the major facilitator superfamily of transporters. Disruption of this gene by translocation has been associated with haplo-insufficiency and renal cell carcinomas. Alternatively spliced transcript variants have been described, but their biological validity has not yet been determined. DIRC2 (Disrupted In Renal Carcinoma 2) is a Protein Coding gene. Diseases associated with DIRC2 include Renal Cell Carcinoma and Renal Cell Carcinoma 4. An important paralog of this gene is FLVCR1.

CAS Number

9007-83-4

Product Name Alternative

Disrupted in renal carcinoma protein 2; Disrupted in renal cancer protein 2

Gene ID

84925

Accession Number

Q96SL1

Reactivity

Human, Mouse

Immunogen

Synthesized peptide derived from part region of human DIRC2 protein at amino acid sequence of 170-250

Clonality

Polyclonal

Tag

DIRC2

Applications

WB, ELISA

Purification Method

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Concentration

1 mg/ml

Molecular Weight

52kD

Precautions

The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Shipping Conditions

Gel pack with blue ice.

Storage Conditions

Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.

Notes

The antibody detects endogenous levels of DIRC2 protein

Observed Molecular Weight

Formulation

Liquid solution

Buffer pH

PBS, 50% glycerol, 0.05% Proclin 300, 0.05%BSA

Applications Notes

Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-2000; ELISA 1:5000-20000